We have updated the company pages to reflect a change to the core team. Angeliki Kotsianti has joined PharmaFlow as Consultant in Medical Governance and Regulatory Strategy. She is a…
Bridgend, UK – 18 September 2025: A new book titled "Transforming the Pharmaceutical Supply Chain" by Hedley Rees, published in September 2025, delves into deep-rooted issues within the pharmaceutical supply…
United States FDA Introduces a New Initiative Readers may be familiar with the words of FDAs Janet Woodcock, MD, in the early 2000s, calling for: “A maximally efficient, agile, flexible…
In Part 1, we concluded that 21st Century cGMP faces critical challenges, given four-decades of strategic realignment of industry business models. Readers wishing to recap can find Part 1 here.…
What is cGMP for the 21st Century? As many reading this will know, cGMP, stands for current Good Manufacturing Practice. It is the quality management system (QMS) FDA mandates for…
What is medicinal product (drug) repurposing? Repurposing a medicinal product (drug or biologic) involves gaining a licence for an already approved, non-patented product, in different indications from that already approved. …
Who would argue that we don't need innovation in biopharmaceuticals? Some are even calling for disruptive innovation, to tackle the thorny issues of affordability and availability of new medical products.…
The answer is 'far less than you would think!' In this STAT article Letting academic medical centers make CAR-T drugs would save billions, medical centres in the US, and their…
PharmaFlow vows to inject transformational strategy into biopharmaceutical value-chains Industry-leading biopharmaceutical supply-chain management consultancy PharmaFlow has today repositioned itself in the market with the launch of a brand-new website and…